Two-day ChemBio Finland 2022 has been rescheluded from March to June.

Biobio-society will organize a seminar titled Future Drugs - what and to whom on June 9th, Helsingin Messukeskus, Hall 3E

Program - Lectures are in English

9:30 - 9:35       Welcome – Dr Hannu Koistinen, Chair of the Biobio society

9:35 - 10:00     Opening lecture

Professor Ullamari Pesonen, University of Turku

Session 1: WHAT (session chair - Dr Mikko Karpale, Biobio society and University of Oulu)

10:00 - 10:20   Therapeutic antibodies

Dr Jaana Vesterinen, Fimea

10:20 - 10:40   RNA-based drugs

Dr Mikko Turunen, Founder/CSO, RNatives Inc.

10:40 - 11:00   Solutions for antibiotic resistance

Professor Marko Virta, University of Helsinki

11:00 - 11:20   Cancer immunotherapy

Professor Juha Klefström, Finnish Cancer Institute, HUS and University of Helsinki

11:20 - 11:40   Repurposing of old drugs - case antidepressants

Professor Eero Castrén, University of Helsinki

11:40 - 12:10   Discussion – All speakers

12:10 - 13:30   Break

Session 2: TO WHOM (session chair - Dr Marc Baumann, Biobio society and University of Helsinki)

13:30 - 13:50   Role of pharmacogenetics in personalized medicine

Professor Mikko Niemi, HUS and University of Helsinki

13:50 - 14:10   Functional precision medicine

Dr Juha Kononen, Chief Medical Officer, Docrates Cancer Center

14:10 - 14:30   Coffee on site

14:30 - 14:50   What costs and who can afford

Vesa Kiviniemi, Head of Assessment, Fimea

14:50 - 15:30   Discussion – All speakers

Sponsors:

Doctoral Program Brain&Mind, University of Helsinki [logo]

chembio2022_9th_june_biobio.pdf

For more information: https://chembio.messukeskus.com/?lang=en